Patient was educated on contraindications for using Dabigatran as follows:
- Dabigatran is not metabolized in the liver and is mainly excreted in the urine. Individuals with history of compromised renal function tend to retain the drug in the circulation longer, thus resulting in toxicity and episodes of bleeding. Dabigatran should be avoided or used with extreme caution in such individuals.
- Dabigatran should be avoided in individuals taking NSAIDs and other blood thinners. Taking Dabigatran along with NSAIDs or other blood thinners concurrently can significantly increase the risk for bleeding episodes.
- Dabigatran should be avoided in individuals with any active bleeding from any wound or surgical site. Using Dabigatran in such individuals can result in uncontrolled hemorrhage and blood loss.
